The Canadian Society for Transfusion Medicine (CSTM) annual conference, held in partnership with Canadian Blood Services and Héma-Québec, took place on May 23-26, 2024, in Saskatoon with the theme of “Bridging transfusion communities.” 

Coinciding with CSTM, Canadian Blood Services' annual Research Day also provided a chance for Canadian Blood Services’ extended research network to collaborate, share their research, and connect. We asked two Canadian Blood Services research trainees to reflect on their experiences and key learnings from these events. Read on for their perspectives! 

This blog was prepared by Mahsa Yazdanbakhsh, a PhD candidate in Dr. Jason Acker’s lab in Edmonton, and Carina Paredes, a PhD candidate in Dr. Sandra Ramirez-Arcos' lab in Ottawa. Mahsa and Carina are recipients of Canadian Blood Services Graduate Fellowship Program as well as travel bursaries to support their attendance at these events. 

1. You both contributed as planning committee members for Research Day 2024; why were you interested in contributing in this way?  

Carina:  

I volunteered for the Research Day organizing committee because I wanted to improve skills such as leadership and organizational abilities and because I believe that actively participating at Research Day is an opportunity for us [trainees] to engage in knowledge dissemination, networking and collaboration that will support our future careers!   

The best part of participating in this event was being an active part of the organizing committee and connecting with trainees, scientists, and managers, which provided me with a great opportunity to network.   

Mahsa:  

I contributed to Research Day 2024 as a planning committee member and moderated a session of presentations. My role involved organizing speaker sessions and supporting team communication. Having attended previous Research Days, I was eager to help enhance the event and being on the planning committee gave me a deeper appreciation for the effort involved while collaborating with a dedicated team. I learned valuable skills in event planning, teamwork, and problem-solving. Additionally, it expanded my network and allowed me to connect with many professionals at Canadian Blood Services.  

It's important for trainees to be involved because it offers leadership experience and fosters a greater connection to the academic community. 

2. Did you also share your research during Research Day and/or CSTM and if so, in what ways? 

Carina:  

I was selected for a Poster presentation at CSTM and I was also able to briefly present it at Research Day. My poster was titled “Role of the efflux pump NorB in survival and increased quinolone resistance of Staphylococcus aureus grown in platelet concentrates.” Staphylococcus aureus is a round-shaped bacterium that is naturally found in the skin and mucosa of healthy humans. It is important to study because contamination of blood components with this bacterium is a major safety threat to transfusion patients. My work aims to unravel the role of a specific gene in antibiotic resistance and virulence of Staphylococcus aureus when grown in platelet components.  

“Having this opportunity to present my work allowed me to receive feedback from peers and experts from different areas of the transfusion medicine. I find this aspect of presenting and sharing my work very important especially because the feedback received will direct me to improve my work and attain stronger research outcomes.” 

Mahsa:  

I presented my research during CSTM and Research Day through a poster and a rapid trainee presentation. My poster was titled, "Osmotic Variability in Red Blood Cells from Different Blood Donor Groups." A typical red blood cell’s lifespan is 120 days. This study compared how younger and older red blood cells from frequent and non-frequent blood donors respond to osmotic changes. Osmotic changes relate to the balance of fluid within a cell. Results showed significant differences in osmotic response among different donor groups, and these results may be useful for optimizing blood product quality and functionality. 

“Sharing research at these events provides an opportunity to disseminate findings to a broader audience within the transfusion community, which is important because the research contributes to existing knowledge in the field and has the potential to influence future research directions and clinical practice.”  

Overall, presenting at Canadian Blood Services’ Research Day and CSTM allows for collaboration, knowledge exchange, and advancements in the field of transfusion medicine, ultimately benefiting patients and health-care providers alike. 

3. How many times have you attended Research Day and CSTM and what was your favourite moment or takeaway this year?  

Carina: 

I attended Research Day and CSTM in 2023 and 2024. I really enjoyed every day of this event, but the highlight of this year was to visit the Vaccine and Infectious Disease Organization (VIDO) facilities in Saskatoon and learn more about their very interesting work. I was very pleased to listen to the keynote speakers at CSTM and their opening remarks. 

Mahsa:  

This marked my third participation in CSTM and second in Research Day, and the highlight was the reunion with familiar faces after a year! Meeting my close friend, whom I hadn't anticipated seeing at CSTM, was particularly delightful and added an extra layer of joy to the event for me. 

4. What would you say to other trainees about Research Day and/or CSTM? 

Carina:  

It’s a great opportunity for improvement and promotes learning, collaboration and innovation. It also allows us trainees to learn from each other's experiences, receive feedback from experts, and improve our individual performance. 

“I would say to other trainees: Participate, be present and get involved! As a trainee, it is important to not only present our research, but also to engage in organizational activities that will build our skill set for our future career.” 

Mahsa:  

I would encourage other trainees to actively participate in both Research Day and CSTM. Attending Research Day provides a platform to present your work and receive constructive feedback, while CSTM offers a broader networking opportunity within the transfusion community. These events offer opportunities for trainees in Canadian Blood Services’ research and education network to share research findings, receive feedback, and network with peers and experts. 

“By participating in these events, you not only contribute to the advancement of knowledge in transfusion medicine but also refine skills and establish connections that can be beneficial for your future endeavors.” 

Canadian Blood Services – Driving world-class innovation  

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact. 

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.  

The Canadian Society for Transfusion Medicine (CSTM) annual conference, held in partnership with Canadian Blood Services and Héma-Québec, took place on May 23-26, 2024, in Saskatoon with the theme of “Bridging transfusion communities.”

Coinciding with CSTM, Canadian Blood Services' annual Research Day also provided a chance for Canadian Blood Services’ extended research network to collaborate, share their research, and connect. Following these events, we asked Canadian Blood Services research trainees to reflect on their experiences and key learnings from the event.

This blog was prepared by Poojan Joshi, a research assistant working with Canadian Blood Services social scientists Drs. Jennie Haw and Kelly Holloway.

What was it like attending your first Canadian Blood Services Research Day and CSTM conference as a research assistant? 

Attending CSTM 2024 for the first time (it was also my first conference ever!) as a social science research assistant was an incredible experience for many reasons. As I listened to the various presentations and engaged with experts in the field, I was struck by the vast array of knowledge and experience attendees brought to the field of transfusion medicine. I was also humbled by the multidisciplinary collaborations that go into building and maintaining an efficient blood system. 

My background includes training in social psychology and qualitative research methods from the University of Guelph, where I developed interest in areas such as health, immigration and refugees, public and media discourse and policy. In December 2022, I had the opportunity to work on a social science research project with Dr. Kelly Holloway and Dr. Jennie Haw titled “Addressing Systemic Barriers to Donation for Donors of African and South Asian Ancestry.” This project aligned very well with my research interests and underscored the importance of applying a broader sociocultural perspective to donation practices and research. I soon realized that my diverse interests were more connected than I had originally thought as I began to understand donation as a complex social act embedded in a wide sociocultural and political context. 

This understanding allowed me to view the presentations, posters, and plenary sessions of Research Day and CSTM 2024 through a social science lens. In doing so, I appreciated the impact that social science has on many aspects of the blood system, from donor to recipient, and the critical role it plays in addressing current and future complex challenges.

“Since joining Canadian Blood Services as a full-time research assistant in September 2023, I’ve gained a deeper understanding of the role of social science in transfusion medicine. 

Under the excellent mentorship of Drs. Kelly Holloway and Jennie Haw, I have developed a profound appreciation for the intersection of these fields and the critical insights social science can bring to transfusion medicine.” 

Thinking about Research Day specifically, what learnings or ideas have the presentations sparked for you?

Dr. Chantale Pambrun’s opening remarks highlighted the importance of the blood operator and how research plays a crucial role in improving transfusion medicine and health, as well as several challenges and opportunities ahead. One significant area where social science has played a key role is in donor policies and changes in deferral criteria. Dr. Mindy Goldman’s presentation noted that because donor policies impact blood safety, public perception, and product availability, a multidisciplinary approach is required to balance donor and recipient safety with the maintenance of an adequate supply.

Dr. Kelly Holloway’s presentation on the lived experiences of immunoglobulin recipients demonstrated the importance of incorporating patient stories to advance our understanding of health and inspire positive change. Immunoglobulin products (Ig) are manufactured from plasma and may be needed by patients with immunodeficiencies or autoimmune and alloimmune disorders. 

What was the most memorable moment from the CSTM 2024 program this year and what reflections did you take away from it?  

Dr. Jennie Haw’s presentation on the systemic barriers to blood donation experienced by donors of African and South Asian ancestry was memorable for me, as it illustrated the strengths and commitment of diverse communities in donating blood and plasma, highlighting the need to address the barriers they face. As I am actively involved in this project, it was powerful to see this perspective of social science shared with experts.

Another memorable session was the plenary on Indigenous health and well-being in Northern Saskatchewan. Presentations by Rena Sutherland, Janet Tootoosis, and Jack Janvier highlighted key considerations for transfusion medicine, such as trust, relationship-building, community engagement, and patient-centred care. They discussed the challenges of providing transfusions in remote areas and emphasized the importance of collaboration, expertise, resources, and clear communication.

The session also addressed the impact of colonialism, including residential schools, ongoing racism, and the exclusion of Indigenous holistic health views to provide guidance on effectively engaging Indigenous communities using a strengths-based approach. Social science research is crucial in these areas as it helps build and maintain trust through community engagement, ensuring inclusive and culturally safe care for donors and recipients. 

“My time at CSTM 2024 was more than just an academic exercise; it was a recognition of the inseparability of social science from the field of transfusion medicine. The talks and discussions illustrated how societal factors are connected to health outcomes and donor policies.”  

I am excited to carry this knowledge forward to the 2024 International Society of Blood Transfusion conference in June, where I hope to take my learning from a Canadian context and expand it by engaging with international experts in transfusion medicine. By fostering interdisciplinary collaborations and supporting innovative approaches, we can ensure that our blood systems not only operate efficiently but also resonate with the voices and needs of all communities.

Read more about social science and diversity in the blood system in these articles on blood.ca:

• Reducing barriers to blood donation in African, Caribbean and Black communities 
• Blood donors mean the world to many with sickle cell disease
• 5 areas a diverse donor base helps save lives (blood.ca) 

Canadian Blood Services – Driving world-class innovation 

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.  

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.  

This blog was originally prepared by CBR communications and programs coordinator Kaitlyn Chuong and former Canadian Blood Services knowledge broker Dr. Travis Sztainert, with edits provided by Abby Wolfe. 

After more than 20 years, the Centre for Blood Research (CBR) and Canadian Blood Services are proud to share that they have renewed their collaboration agreement which supports education, training and knowledge mobilization for the next generation of trainees and researchers in blood science and transfusion at CBR.  

The collaboration agreement which is administered by Innovation and Portfolio Management at Canadian Blood Services has recently been extended for three more years to 2027. This agreement formalizes the next iteration of this long-standing partnership and is the result of continued commitment from both organizations to improve blood research.  

This partnership emerged in response to recommendations made following Canada’s public inquiry into the contaminated blood crisis of the 1980s and 1990s. Thus, to address a recognized gap in transfusion science knowledge, in 2002, a group of visionary blood researchers at the University of British Columbia (UBC) established Canada’s first interdisciplinary blood research centre — an entirely unique and valuable resource for established and emerging blood scientists. With its creation, the CBR brought together a wide range of multi-talented investigators to develop highly specialized labs to study blood and transfusion science. Since its inception, the CBR has grown to include more than 35 basic science, applied science, social science and clinical investigators in 12 departments, representing 6 faculties at UBC, with a focus on advancing knowledge of transfusion science and medicine in the lab and in the clinic.  

"We are delighted to extend our partnership with the Centre for Blood Research through 2027. This renewal highlights our shared commitment to advancing education, training, and research in transfusion science. Together, we aim to drive innovation and improve transfusion practices, ensuring a safer and more effective future for the Canadian blood system." 

Dr. Chantale Pambrun
Senior Medical Director, Innovation & Portfolio Management 

“The long-term relationship of Canadian Blood Services and the CBR has been nothing less than fantastic! By combining resources and sharing knowledge, education and research outputs, this unique partnership has resulted in more rapid and meaningful advances that are recognized locally, nationally and internationally. The entire transfusion medicine community has benefitted and will continue to do so.”  

Dr. Ed Conway
Director of the Centre for Blood Research

The partnership of Canadian Blood Services was integral to creating the Centre for Blood Research, providing essential start-up funding and continuing to support infrastructure for the centre and its training and education programs. Several Canadian Blood Services scientists are active members within the Centre for Blood Research including senior scientist Dr. Ed Pryzdial and adjunct scientists Dr. Ed Conway, Dr. Hongshen Ma and Dr. Jay Kizhakkedathu. 

Learn more about some of the research these scientists and members of their labs undertake in our previous R.E.D. blogs and videos:  

• Pryzdial lab: Investigating envelope viruses (blood.ca) 
• Ma lab: A novel microfluidic device to aid in the search for red blood cell "super-storers" 
• Graduate trainees: Recipients of the Canadian Blood Services Graduate Fellowship Program  

The CBR is grateful for Canadian Blood Services’ continuous support, without which its many educational, training and research programs would not be possible. This includes, for example, CBR’s Graduate Award Program and Summer Studentship Program, as well as the CBR's weekly seminar series and the annual Earl W. Davie and Norman Bethune symposia. 

Canadian Blood Services – Driving world-class innovation  

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.   

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency. 

Dr. Donald R. Branch’s work as a discovery scientist at Canadian Blood Services focuses on immunotherapy, seeking to further enhance understanding of the cellular and molecular mechanisms involved in autoimmune diseases. Based in Toronto, Dr. Branch’s laboratory develops models of rheumatoid arthritis, Alzheimer’s disease, immune thrombocytopenia (ITP) and multiple sclerosis in mice. These models are particularly useful in examining how cells affected by these conditions respond to current therapeutic agents like intravenous immunoglobulin – a blood product made from human plasma commonly known as IVIg – and investigating potential alternative therapeutics.  

Over the years, Dr. Branch’s lab research findings have included the discovery of a special reagent that makes identification of antibodies easier by “zapping" autoantibodies,  answers around unexpected side effects of IVIg therapy, and insights around recipients’ responses to bone marrow transplantation. It has also earned him numerous awards and accolades, including four from AABB, the Association for the Advancement of Blood & Biotherapies.

New knowledge about neutrophils

Recently, contributions from Dr. Branch’s lab helped a U.K.-based team of researchers discover new information about how neutrophil function and activity is regulated. Neutrophils are a type of white blood cell that are part of the body’s normal immune response. A person’s neutrophil levels may be affected by infections as well as chronic or acute illnesses. Patients who have very low neutrophil counts and/or persistent infections may receive a boost to their neutrophil levels via granulocyte transfusion therapy. However, in some diseases, overactivation of neutrophils can also create an inflammatory environment and harm healthy tissue.

The research has been published in the high-impact scientific journal, Nature. This publication has filled a gap in knowledge about the mechanisms involved in maintaining balance between neutrophils’ infection-fighting power and inflammation-causing potential. As Dr. Branch describes: “This research by Dr. Brown and team shows that the myeloid inhibitory C-type lectin enzyme, which is known as MICL, controls neutrophil activity in rheumatoid arthritis. It is likely that MICL also regulates neutrophil activity in general. This suggests that if therapeutics can be designed to target MICL, they may be useful in controlling inflammation and infection. It is a fundamental finding that will change our understanding of the biology of neutrophils.”  

Discovery research, like the study to which Don and Ruqayyah contributed, is essential to improving patient care in the long run. New biomedical insights are essential to crafting new drugs and new therapeutic approaches in a rational way.

Dr. William (Bill) Sheffield, Canadian Blood Services senior scientist and associate director of research

Discovery research expertise leads to new collaboration  

The special mouse model that Dr. Branch’s lab uses is known as K/BxN. In this model, two mouse populations are selectively bred to produce offspring whose genetic material carry an antibody that destroys bone cartilage. An arthritis-causing serum containing this destructive antibody can then be obtained from the mice for use as a reagent in research. This process is termed “serum-transfer arthritis” and has been used by many investigators in the study of treatments that may alleviate the condition. 

Knowledge of Dr. Branch’s lab’s expertise in this area prompted a connection to the team of researchers at the Universities of Exeter and Aberdeen in the U.K. for this study. Says Dr. Branch, “In 2021, I supported a successful application to Canadian Blood Services’ Blood Efficiency Accelerator Program (BEAP) by Dr. Maria Fernandes, a researcher from  Héma-Québec who works with neutrophils. Through this collaboration, Dr. Fernandes was aware that I work on rheumatoid arthritis with K/BxN mice, and she also knew that Dr. Gordon Brown in the U.K. was looking to collaborate with a researcher in this area for some planned neutrophil research. My lab, which included postdoctoral fellow Dr. Ruqayyah Almizraq at the time, contributed to Dr. Brown’s research by providing the sera from our K/BxN mice. With this sera, Dr. Brown and his collaborators were able to induce rheumatoid arthritis and show that it could be resolved by removing the inhibition of a specific enzyme.”  

Science that is never boring

The Branch lab is currently using these same mouse models to investigate whether a recombinant protein called IgG1 Fc hexamer could be an effective replacement for IVIg in the treatment of autoimmune conditions like rheumatoid arthritis and ITP. While early results are promising, continued work is needed. In fact, back in 2018, Dr. Branch was asked in a previous R.E.D. blog post to describe what he found to be the most exciting part of science. Reflecting on the same question now, he reiterates that his response still rings true after 50 years in the field:   

The most exciting part of science is that when you do good science, you get more questions than you get answers, which means it is never boring. There is no end to imagination; new ideas, theories, experiments and discoveries occur often and provide a level of excitement to which many other professions cannot attest.

Dr. Donald (Don) Branch, Canadian Blood Services senior scientist

Canadian Blood Services – Driving world-class innovation 

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.   

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency. 

Dr. Melika Loriamini! 

This new award, in honour of Dr. Dana Devine, supports early career scientists in a field related to transfusion science and medicine, blood banking and blood biotherapies. It is awarded in collaboration with the Canadian Society for Transfusion Medicine’s at their annual conference. 

“I truly appreciate the Committee for the recognition and I'm so proud that I'm the first person to win the Dana Devine Award,” Dr. Loriamini says. “When I walked into the conference, I felt like I was famous because everyone knew who I was. It was a great feeling that all the work, all the hard work, during these years that I did, it's now acknowledged, and everyone knows it.” 

Dr. Loriamini began her career in medical laboratory science in Iran, obtaining a Bachelor of Science degree before immigrating to Canada. She completed a second Bachelor’s degree, this time in biomedical science from York University, and went on to enroll in the laboratory medicine and pathobiology PhD program at the University of Toronto. While completing her education, Dr. Loriamini worked as a Medical Laboratory Technologist at LifeLabs and the William Osler Hospital. 

As part of her PhD, Dr. Loriamini worked with Canadian Blood Services Senior Scientist Dr. Donald Branch which she says allowed her to “acquire expertise in the fields of transfusion medicine and immunology and we were able to publish various articles.” 

In fact, it was Dr. Branch who first sent her the application for the award and told her he thought she was a strong candidate. 

“I want to say thanks to Dr. Branch, who was my supervisor. Actually, thank you is not enough,” Dr. Loriamini says. “He taught me how to think as a scientist and how to become a scientist. I truly appreciate him. He always trusted me.” 

Dr. Loriamini’s research focused on developing a new drug to help people who have autoimmune cytopenias — a cluster of conditions which causes your immune system to attack your own healthy blood cells. She was able to identify a potential drug which is expected to undergo clinical trials in the future.

In addition to receiving the Canadian Blood Services Dana Devine Award, Dr. Loriamini has also been recognized with the Canadian Blood Services Graduate Fellowship Program award in 2019 and 2021, the AABB Outstanding Abstract Award for Trainees as a Fellow/Post-Doctoral Student in 2022, the SGS travel award from the University of Toronto in 2022, the Best Poster for Translation/Basic research award from Hematology Academic Day in 2023, and the Best Poster for Infectious Diseases, Inflammation, and Immunology award from the 2023-Laboratory Medicine & Pathobiology Research Conference. 

Dr. Loriamini is now a Clinical Practice Leader at Humber River Health in Toronto which allows her to bring her research to a clinical setting. Congratulations Dr. Melika Loriamini! 

Canadian Blood Services – Driving world-class innovation

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.  

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.